Zhengye Biotechnology Holding Limited Contract Liability (Deferred Revenue)
Zhengye Biotechnology Holding Limited (ZYBT) had Contract Liability (Deferred Revenue) of CNY 4.75 million as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-04-28
- 2025-12-31: Contract with Customer, Liability, Current 4.75M CNY.
- 2025-06-30: Contract with Customer, Liability, Current 5.00M CNY.
- 2024-12-31: Contract with Customer, Liability, Current 3.48M CNY.
- 2023-12-31: Contract with Customer, Liability, Current 3.88M CNY.
CNY
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2025-12-31 | 4.75M CNY 20-F · filed 2026-04-28 |
| 2025-06-30 | 5.00M CNY 6-K · filed 2025-12-12 |
| 2024-12-31 | 3.48M CNY 20-F · filed 2026-04-28 |
| 2023-12-31 | 3.88M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2025-12-31 | $680.00K 20-F · filed 2026-04-28 |
| 2025-06-30 | $698.00K 6-K · filed 2025-12-12 |
| 2024-12-31 | $477.00K 20-F · filed 2025-07-03 |